相关实验视频
Updated: Jul 9, 2025

07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
19.5K
对败血症的HAT治疗:对治疗理由和当前临床评估状态的审查
Yali Sun1,2, Yongfang Yang2, Zhuoyi Ye2
1Department of General ICU, The First Affiliated Hospital of Zhengzhou University, Henan Key Laboratory of Critical Care Medicine, Zhengzhou Key Laboratory of Sepsis, Zhengzhou 450052, Henan, China.
Journal of intensive medicine
|November 29, 2023
概括
皮,维生素C和胺 (HAT) 治疗对败血症有希望,但需要更多的临床证据. 这次审查审查了HAT.
科学领域:
- 关键护理医学 关键护理医学
- 营养生物化学 营养生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症是一种危及生命的器官功能障碍,是由宿主对感染反应失调引起的.
- 传统的败血症治疗侧重于抗生素和器官支持.
- 新兴疗法旨在调节宿主反应并改善结果.
研究的目的:
- 审查使用皮,维生素C和胺 (HAT) 疗法在败血症中的理论理由.
- 根据观察性研究和随机对照试验,评估HAT治疗的临床疗效.
- 为未来HAT治疗在败血症管理中的临床应用提供见解.
主要方法:
- 在文献中搜索评估HAT治疗败血症的研究.
- 对观察性研究和随机对照试验 (RCT) 的分析.
- 综合有关HAT治疗的安全性和疗效的数据.
主要成果:
- HAT疗法具有治疗败血症的合理生物机制.
- 从观察性研究和RCT中获得的关于HAT疗法的疗效的临床证据目前尚不确定.
- 需要进一步的高质量研究来证实其临床益处.
结论:
- HAT疗法是一种具有强大的理论基础的毒症的潜在辅助治疗方法.
- 目前的临床证据不足以推常规HAT治疗.
- 需要更严格的临床试验来确定HAT治疗在败血症治疗中的作用.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Pneumonia IV: Management
333
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
333
Acute Respiratory Failure-V
142
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
142
Electroconvulsive Therapy
44
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
44
Pleural Effusion II: Symptoms and Management
183
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
183

